<p>The analysis included 342 MDR-TB/HIV co-infected patients, of whom 28.4% had unfavorable treatment outcome. After a follow-up of 4359 person-months, median survival time was 30 months with incident rate of 22 per 1000 person months. MDR-TB/HIV co-infected patients with normal nutrition status had better survival probabilities (log-rank test P&lt;0.001). However MDR-TB/HIV co-infected patients on ART had shorter survival probabilities (log-rank test P = 0.46). Malnutrition was significantly associated with being unfavourable treatment outcomes among MDR-TB/HIV co-infected patients (adjusted Hazard ratio =2.57 95% CI, 1.63-4.04).</p>